FIRST LICENSED MELATONIN FOR SLEEP DISORDERS IN CHILDREN AND ADOLESCENTS WITH ADHD LAUNCHES IN UK
Swedish Pharmaceutical Company, AGB-Pharma, has recently launched Adaflex, the UK’s first melatonin product for insomnia in children and adolescents aged 6-17 years old with ADHD (where sleep hygiene measures have been insufficient). Melatonin has long been understood as an effective and safe treatment for ...
United Kingdom City Of Fredrik Lindberg Public Health Scandj Public Health Swedish Pharmaceutical Company
Source: pharmiweb.com